Stopping a GLP-1: Planning for Appetite, Weight Maintenance, and Follow-Up

A practical discussion guide for planning GLP-1 discontinuation or a longer interruption, with attention to appetite, health goals, and ongoing follow-up.
Woman writing a grocery list while checking food in her refrigerator.

Stopping a GLP-1 medication deserves a follow-up plan. Appetite, weight, and the health measures being treated may change after medication is withdrawn. Before a planned stop or longer interruption, discuss the reason, what to monitor, and when to reconnect with your prescribing clinician. This guide helps organize that conversation; it does not provide a taper, missed-dose rule, or restart schedule.

Perhaps cost has changed, side effects are difficult, or you are wondering what happens after reaching a goal. Those are different situations. Begin by naming the problem you need the prescribing team to solve instead of assuming that everyone should take the same next step.

What withdrawal studies can tell you

In the STEP 1 extension, researchers followed a subset of adults without diabetes after semaglutide treatment and the trial's lifestyle intervention ended. Weight regain occurred on average during the following year. Because both interventions ended, the study does not isolate medication withdrawal from the loss of structured support. It also does not predict an individual's experience. Read the STEP 1 extension.

SURMOUNT-4 studied continued tirzepatide treatment versus switching to placebo after an initial treatment period. Participants who switched to placebo regained weight on average, while continued treatment better maintained the initial reduction. Tirzepatide acts on both GIP and GLP-1 receptors; these findings should not be treated as identical results for every weight-management medicine. The trial excluded diabetes. Both studies had manufacturer involvement. Read SURMOUNT-4.

The useful takeaway is a planning question: what support will remain if the prescription changes? A study average cannot answer that for you.

Start with the reason for stopping

Prepare one sentence that describes your situation. For example, “My next refill is uncertain,” or “I want to understand the maintenance options after reaching my goal.” These are hypothetical examples, not patient cases.

Then gather the exact medication name, formulation, prescribed directions, last dose taken, and other medicines. If the medicine also treats diabetes or another condition, make sure the clinician responsible for that condition is involved. A weight goal alone does not describe the entire purpose of a prescription.

Do not stretch out doses, use someone else's supply, combine products, or restart an old regimen to work around an access problem. Ask the prescribing team for product-specific instructions. Momentum's GLP-1 side-effects guide addresses a different question: symptoms that need monitoring or medical attention while using treatment.

A maintenance conversation you can bring to a visit

Use this original discussion worksheet to record the plan in the clinician's own terms. It is not a medical scoring tool.

Planning questionWhat to write down
Why is the treatment changing?The specific concern, preference, health issue, or access problem.
What remains part of the plan?Nutrition support, appropriate activity, and other care already agreed with the team.
Which measures matter for me?The clinician's chosen weight, symptom, function, or health measures and how often to review them.
What should prompt contact sooner?Individual instructions for appetite changes, concerning symptoms, or difficulty following the plan.
When is the next review?A date, the responsible clinician, and the correct contact route.
What if circumstances change again?Who to call before a restart, switch, or further interruption.

Make the answers specific enough to use. “Follow up if needed” leaves more uncertainty than a named contact and an agreed review date. Ask for clarification if you do not know who will manage the next prescription decision.

Review more than a single scale reading

Ask which observations would be useful between visits. Possibilities to discuss include hunger patterns, difficulty organizing meals, changes in strength or daily activity, and the trend in any measurements your team has requested. You do not need to invent an intensive tracking routine or react to every daily fluctuation.

Choose a manageable way to keep notes. A brief entry describing what changed and when can be more useful than an unexplained number. If weighing causes distress, say so and discuss another way to support the clinical review. The monitoring method should fit the person as well as the treatment goal.

For the separate question of preserving function during weight loss, see GLP-1 medications, muscle loss, and strength.

What this plan cannot promise

No checklist guarantees that weight will remain unchanged after stopping. The withdrawal trials do not establish a universal taper or prove that replacing medication with a supplement or peptide preserves its effects. A decision to stop, continue, or change treatment requires individual assessment.

If side effects or a new health concern are driving the decision, contact the prescriber promptly instead of waiting to complete a worksheet. Seek emergency help for an immediately dangerous symptom. Follow the current instructions supplied with your specific medicine.

Discuss your next step with Momentum

If you are exploring medically supervised weight management, bring your medication details and maintenance questions to a consultation. Call (844) 664-7246. If another clinician prescribes your current medicine, coordinate changes with that team.

Prepared by Momentum Medical for patient education. The cited studies inform the research summary; the worksheet is an editorial conversation aid. Individual medical decisions require your treating clinician.

Featured image: Stock photograph; model shown for illustration. © jovannig / Adobe Stock.

Request a consultation:

Contact Form